All News and Press Releases
Enter any phrase or word you would like to search for and click .
PostNews: Press Release
European Patent Office intends to grant PHI patent on synthetic antibodies
PHI AB announces today that the European Patent Office (EPO) intends to grant a patent on synthetic antibodies.
PostNews
BioStock: PHI’s CEO reflects on global roadshow success
BioStock contacted CEO Patrik Eschricht to learn about the team’s achievements on their global roadshow this early summer.
PostNews: Interim Report
Interim Report 4 2022/23
Sales continue to grow, and the year ended up with the highest turnover for a year in PHI, so far.
PostNews: Press Release
Notice that Interim Report 4 2022/23 will be published on June 26, 2023
PHI changes the date for publication of Interim Report 4 2022/23 to June 26, 2023.
PostNews: Press Release
PHI’s new HoloMonitor M4FL premiers at major scientific conferences
PHI introduces the HoloMonitor M4FL system to the global scientific community at two major scientific conferences this June.
PostNews: Press Release
PHI AB’s warrant exercise registered with the Swedish Companies Registration Office
PHI today announces that the new shares from the exercise of warrants of series TO 3 have been registered with the Swedish Companies Registration Office.